Bulut Gökten D, Mercan R. Clinical Outcomes after Switching from Originator Infliximab to the Biosimilar Ixifi in Patients with Axial Spondyloarthritis: A Single-Center Study from Türkiye. Rheumatol Bul [Internet]. 2026 May 1 [cited 2026 Nov. 3];34(1):4-20. Available from: https://www.rheumatologybg.org/journal/rbj/article/view/100